PMAM
ICPT

Picton Mahoney Asset Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Picton Mahoney Asset Management’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-15,700
Closed -$3.71K – 402
2014
Q3 		$3.71K Sell
15,700
-18,350
-54% -$4.68M 0.2% 110
2014
Q2 		$8.06K Sell
34,050
-19,600
-37% -$5.17M 0.47% 74
2014
Q1 		$17.7M Sell
53,650
-111,550
-68% -$37.6M 1.02% 23
2013
Q4 		$11.3M Buy
165,200
+98,400
+147% +$5.69M 0.66% 51
2013
Q3 		$4.61M Buy
+66,800
New +$3.3M 0.3% 102

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Picton Mahoney Asset Management's ICPT Position: Q4 2014 in Review

Picton Mahoney Asset Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2014, closing a stake of 15,700 shares — an estimated $3.71K sold.

Picton Mahoney Asset Management first reported a position in ICPT in Q3 2013 and held it in 5 quarters. The position peaked at $17.7M in Q1 2014. 169 funds tracked by Wall St. Rank hold ICPT as of Q4 2014.

  • Picton Mahoney Asset Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2014 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 15,700 Intercept Pharmaceuticals, Inc. shares in Q4 2014, an estimated $3.71K.
  • Picton Mahoney Asset Management first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2013 and held it in 5 quarters.
  • Picton Mahoney Asset Management's Intercept Pharmaceuticals, Inc. position peaked at $17.7M in Q1 2014.
  • 169 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2014.

Based on Picton Mahoney Asset Management's 13F filing for Q4 2014, filed 13 Feb 2015.